MYD88 and type 1 diabetes mellitus: Interestingly, our results revealed that MyD88 signaling in myeloid cells plays an important pathogenic role for the development of T1D in the STZ model, but is less critical for T1D development in the NOD model where it seems to contribute by accelerating the onset but is not required for the overall incidence and development of the disease.